BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Symlin (pramlintide) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Symlin (pramlintide)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03560960-130@assetmemo.bio
DTSTAMP:20261121T004021Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:Symlin (pramlintide): Phase 1 readout est. (NCT03560960)
DESCRIPTION:Symlin (pramlintide)\, phase 1.\nStudy: Multi-Center Developmen
 t of a Novel Diagnostic Test for Alzheimer's Disease\nEstimated primary co
 mpletion: November 2026. This is a ClinicalTrials.gov estimate\, not a con
 firmed readout date\, and it can move.\nDrug page: https://assetmemo.bio/d
 rug/pramlintide#upcoming-events\nRegistry record: https://clinicaltrials.g
 ov/study/NCT03560960
URL:https://assetmemo.bio/drug/pramlintide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07914621-130@assetmemo.bio
DTSTAMP:20261121T004021Z
DTSTART;VALUE=DATE:20270131
DTEND;VALUE=DATE:20270201
SUMMARY:Symlin (pramlintide): Phase na readout est. (NCT07914621)
DESCRIPTION:Symlin (pramlintide)\, phase na\, Type 1 Diabetes.\nStudy: Outp
 atient Pramlintide Study\nEstimated primary completion: 31 January 2027. T
 his is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and 
 it can move.\nDrug page: https://assetmemo.bio/drug/pramlintide#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07914621
URL:https://assetmemo.bio/drug/pramlintide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT07679516-130@assetmemo.bio
DTSTAMP:20261121T004021Z
DTSTART;VALUE=DATE:20280531
DTEND;VALUE=DATE:20280601
SUMMARY:Symlin (pramlintide): Phase na readout est. (NCT07679516)
DESCRIPTION:Symlin (pramlintide)\, phase na.\nStudy: Postprandial Regulatio
 n of Bone Perfusion in Healthy Individuals\nEstimated primary completion: 
 May 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout 
 date\, and it can move.\nDrug page: https://assetmemo.bio/drug/pramlintide
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT076
 79516
URL:https://assetmemo.bio/drug/pramlintide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
